Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Prostate Cancer

Free Subscription Articles published in Endocrinology Retrieve available abstracts of 16 articles: HTML format

Single Articles

June 2023
1. COLLDEN H, Hagberg Thulin M, Landin A, Horkeby K, et al
   Dietary Progesterone Contributes to Intratissue Levels of Progesterone in Male Mice.
   Endocrinology. 2023;164:bqad103.
   PubMed     Abstract available
   
   
   May 2023
2. HAHN AW, Siddiqui BA, Leo J, Dondossola E, et al
   Cancer Cell-Extrinsic Roles for the Androgen Receptor in Prostate Cancer.
   Endocrinology. 2023 May 16:bqad078. doi: 10.1210.
   PubMed     Abstract available
   
   
   
3. LEO J, Dondossola E, Basham KJ, Wilson NR, et al
   Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer.
   Endocrinology. 2023 May 8:bqad071. doi: 10.1210.
   PubMed     Abstract available
   
   
   March 2023
4. KHATIWADA P, Rimal U, Han Z, Malla M, et al
   The Transmembrane Protein TM4SF3 Interacts With AR and AR-V7 and is Recruited to AR Target Genes.
   Endocrinology. 2023;164:bqad048.
   PubMed     Abstract available
   
   
   January 2023
5. NOURUZI S, Tabrizian N, Zoubeidi A
   Beyond expression: role of phosphorylated residues of EZH2 in lineage plasticity in prostate cancer.
   Endocrinology. 2023 Jan 30:bqad023. doi: 10.1210.
   PubMed     Abstract available
   
   
   
6. MICHAEL P, Roversi G, Brown K, Sharifi N, et al
   Adrenal Steroids and Resistance to Hormonal Blockade of Prostate and Breast Cancer.
   Endocrinology. 2023;164:bqac218.
   PubMed     Abstract available
   
   
   November 2022
7. HARDAWAY AL, Goudarzi M, Berk M, Chung YM, et al
   5-Hydroxyeicosatetraenoic Acid Controls Androgen Reduction in Diverse Types of Human Epithelial Cells.
   Endocrinology. 2022;164:bqac191.
   PubMed     Abstract available
   
   
   October 2022
8. HAN Z, Rimal U, Khatiwada P, Brandman J, et al
   Dual Acting Peptides Target EZH2 and AR: a New Paradigm for Effective Treatment of Castration-Resistant Prostate Cancer.
   Endocrinology. 2022 Oct 26. pii: 6775160. doi: 10.1210.
   PubMed     Abstract available
   
   
   September 2022
9. EICKHOFF N, Bergman AM, Zwart W
   Homing in on a moving target: Androgen Receptor cistromic plasticity in prostate cancer.
   Endocrinology. 2022 Sep 20. pii: 6705578. doi: 10.1210.
   PubMed     Abstract available
   
   
   
10. EL KHARRAZ S, Dubois V, Launonen KM, Helminen L, et al
    N/C Interactions Are Dispensable for Normal In Vivo Functioning of the Androgen Receptor in Male Mice.
    Endocrinology. 2022;163.
    PubMed     Abstract available
    
    
    May 2022
11. UNTERBERGER CJ, Maklakova VI, Lazar M, Arneson PD, et al
    GH Action in Prostate Cancer Cells Promotes Proliferation, Limits Apoptosis, and Regulates Cancer-related Gene Expression.
    Endocrinology. 2022;163.
    PubMed     Abstract available
    
    
    January 2022
12. MOZAR F, Sharma V, Gorityala S, Albert JM, et al
    Downregulation of Dihydrotestosterone and Estradiol Levels by HEXIM1.
    Endocrinology. 2022;163.
    PubMed     Abstract available
    
    
    August 2021
13. MAUVAIS-JARVIS F
    Do Anti-androgens Have Potential as Therapeutics for COVID-19?
    Endocrinology. 2021;162.
    PubMed     Abstract available
    
    
    July 2021
14. LUDWIG M, Rajvansh R, Drake JM
    Emerging Role of Extracellular Vesicles in Prostate Cancer.
    Endocrinology. 2021 Jul 7. pii: 6316765. doi: 10.1210.
    PubMed     Abstract available
    
    
    June 2021
15. VALLE S, Sharifi N
    Targeting glucocorticoid metabolism in prostate cancer.
    Endocrinology. 2021 Jun 28. pii: 6310612. doi: 10.1210.
    PubMed     Abstract available
    
    
    January 2021
16. GANGULY S, Naik D, Muskara A, Mian OY, et al
    The Nexus of Endocrine Signaling and Cancer: How Steroid Hormones Influence Genomic Stability.
    Endocrinology. 2021;162.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.